title: [Treatment guidelines for age-related macular degeneration].
abstract: We describe treatment guidelines for age-related macular degeneration (AMD) in Japan in line with the accepted classification and diagnostic criteria of AMD in Japan. A working group of five members drew up an AMD treatment algorithm based on a comprehensive review of foreign guidelines and recent data gathered in Japan. We applied lifestyle and dietary modifications and anti-oxidative supplementation to the prodromal stage of AMD and atrophic AMD. We recommend that, depending on the type of disease (typical AMD, polypoidal choroidal vasculopathy, or retinal angiomatous proliferation), an anti-vascular endothelial growth factor drug,
authors: Department of Ophthalmology, Kansai Medical University, 2-3-1 Shin-machi, Hirakata-shi, Osaka-fu 573-1191, Japan. takahask@hirakata.kmu.ac.jp
authors: Kanji
authors: K
authors: Takahashi
authors: Yuichiro
authors: Y
authors: Ogura
authors: Tatsuro
authors: T
authors: Ishibashi
authors: Fumio
authors: F
authors: Shiraga
authors: Mitsuko
authors: M
authors: Yuzawa
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D007564:Japan; D008268:Macular Degeneration / Q000175:diagnosis / Q000628:therapy; D016491:Peripheral Vascular Diseases / Q000175:diagnosis / Q000628:therapy; D010778:Photochemotherapy; D017410:Practice Guidelines as Topic
chemical_list: D000975:Antioxidants